Five decades on, Spain court convicts thalidomide maker

November 20, 2013

A court ordered the German maker of the banned pregnancy drug thalidomide to compensate Spanish victims who suffered birth defects from it in the 1960s, in a ruling released Wednesday.

The Spanish victims' group that brought the suit said it would be the first time ever that the German firm Grunenthal had been ruled responsible for the scandal, although it has already compensated some victims.

The case was the first suit brought in Spain against the manufacturer of the which the plaintiffs said caused in up to 3,000 Spanish babies.

Avite, an association representing Spaniards born with severe defects after their mothers took the drug during their pregnancies, had sought compensation of 204 million euros ($275 million) for its members.

In a written ruling dated Tuesday, the court said it convicted Grunenthal and sentenced it "to compensate each one of the plaintiffs" to tens of thousands euros each, depending on the severity of their disability, and to pay legal costs.

It did not specify exactly how many plaintiffs there were nor how much the compensation and costs would add up to in total. Avite claims to have 180 members.

Dozens of Spaniards born with defects caused by thalidomide, many in wheelchairs or on crutches, attended the trial in Madrid last month.

Thalidomide was originally marketed as a sedative, but from the late 1950s was prescribed to women around the world to combat morning sickness.

Many of the children of the mothers who took the drug were born with abnormally short limbs and in some cases without any arms, legs or hips.

In late 1961 the drug was withdrawn from the British and German markets, but it continued to be sold in other countries including Canada and Japan for months more.

Avite said it remained available in Spain until 1965.

The drug is estimated to have caused deformities in 10,000-20,000 babies in some 40 countries.

Grunenthal did not publicly apologise for the scandal until 2012.

Avite said in a statement ahead of the trial that it hoped the "historic lawsuit (would) appease the suffering of Spanish victims, which began in their mothers' wombs and continues today, with the amputation of their arms and legs".

Explore further: Spain court hears case against German maker of Thalidomide (Update)

Related Stories

Spain court hears case against German maker of Thalidomide (Update)

October 14, 2013
A Madrid court on Monday heard Spain's first lawsuit against German firm Grunenthal, the manufacturer of the morning sickness drug thalidomide which caused birth defects in thousands of babies.

Victims: Thalidomide sold in Spain post-withdrawal

May 8, 2013
(AP)—Spanish victims of thalidomide on Wednesday published documents they claim prove a German drug company kept distributing the notorious drug in Spain six months after it was taken off the market in other countries.

Australian wins millions in Thalidomide lawsuit

July 18, 2012
(AP) — An Australian woman born without arms and legs after her pregnant mother took the anti-morning sickness drug Thalidomide has reached a multimillion dollar settlement with the medicine's British distributor, her ...

Thalidomide maker 'ignored birth defects for years'

July 27, 2012
The German makers of thalidomide were warned of birth defects years before it was withdrawn and Australian distributors used pregnant women as the world's first test subjects, court papers alleged Friday.

Australian woman wins thalidomide hearing: court

December 19, 2011
A woman born without arms or legs on Monday won the right to have the class action she is leading against the firms behind thalidomide, a sedative blamed for birth defects, proceed in Australia.

Recommended for you

Novel botulinum toxin compound relieves chronic pain

July 18, 2018
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to research by UCL, ...

FDA recalls heart medication valsartan, citing cancer concerns

July 17, 2018
The U.S. Food and Drug Administration issued a voluntary recall of several medications that contain the active ingredient valsartan, which is used to treat high blood pressure and heart failure.

Opioids given too easily to children: study

July 16, 2018
(HealthDay)—Many children are prescribed powerful opioid painkillers they don't really need, putting them and those around them at risk, a new study shows.

Study reveals opioid patients face multiple barriers to treatment

July 12, 2018
In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found.

Report details possible conflict of interest issues for FDA advisors

July 6, 2018
Charles Piller, a contributing correspondent for the journal Science, has published a Feature piece in the journal detailing what he describes as possible conflicts of interest issues by people who serve as advisors to the ...

Opioid epidemic responses overlook gender

July 5, 2018
Yale health experts warn that current efforts to confront the growth of opioid addiction and overdose deaths must better incorporate an understanding of how women fit into this epidemic.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.